0001606498-23-000035.txt : 20230323
0001606498-23-000035.hdr.sgml : 20230323
20230323113104
ACCESSION NUMBER: 0001606498-23-000035
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230306
FILED AS OF DATE: 20230323
DATE AS OF CHANGE: 20230323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greiner Michael
CENTRAL INDEX KEY: 0001520392
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36440
FILM NUMBER: 23755020
MAIL ADDRESS:
STREET 1: C/O VISTAPRINT
STREET 2: 95 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVANOS MEDICAL, INC.
CENTRAL INDEX KEY: 0001606498
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 464987888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5405 WINDWARD PARKWAY
STREET 2: SUITE 100 SOUTH
CITY: ALPHARETTA
STATE: GA
ZIP: 30004
BUSINESS PHONE: 844-428-2667
MAIL ADDRESS:
STREET 1: 5405 WINDWARD PARKWAY
STREET 2: SUITE 100 SOUTH
CITY: ALPHARETTA
STATE: GA
ZIP: 30004
FORMER COMPANY:
FORMER CONFORMED NAME: Avanos Medical, Inc.
DATE OF NAME CHANGE: 20180702
FORMER COMPANY:
FORMER CONFORMED NAME: Halyard Health, Inc.
DATE OF NAME CHANGE: 20140424
4/A
1
wf-form4a_167958545286655.xml
FORM 4/A
X0407
4/A
2023-03-06
2023-03-07
0
0001606498
AVANOS MEDICAL, INC.
AVNS
0001520392
Greiner Michael
5405 WINDWARD PKWY
ALPHARETTA
GA
30004
0
1
0
0
SVP - Chief Financial Officer
0
Common Stock
2023-03-06
4
A
0
34619
0
A
129050
D
Common Stock
2023-03-06
4
F
0
3037
29.62
D
126013
D
Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
Total beneficially owned includes 339 shares acquired on December 30, 2022 and 327 shares acquired on June 30, 2022 under the Issuer's Employee Stock Purchase Plan.
Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
This Form 4/A is being filed to correct an error in the calculation of the number of time-based restricted share units issued to the Reporting Person on March 6, 2023 pursuant to the Issuer's 2021 Long Term Incentive Plan.
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
2023-03-23